Page 100 - IMO-1-1
P. 100

Innovative Medicines & Omics                                           SARS-CoV-2 inhibition by quinolines



                          A                                  B









                          C                                  D













            Figure 3. Cytotoxic effect of quinoline derivatives in Vero E6 and Calu-3 cells. High cell viability was observed in both cellular models when treated with
            Q1a – Q4a (A and C), Q1b – Q4b, and Q1bS (B and D) at a concentration curve (5 – 160 µM). The R  values ranged from 0.8 to 0.9 (n = 4).
                                                                             2
            Table 3. Total conformations in closed, intermediate, or open   Table 5. Biological activity of compounds based on CC ,
                                                                                                        50
            states for chains A and B                          EC , and SI values in Vero E6 cells
                                                                  50
            Conformation     Chain A     Chain B     Total     Molecules                  Vero E6
            Closed           20,721      6,174       26,895                    CC 50              24 hpi
            Intermediate     8,336       13,812      22,148                                  EC 50        SI
            Open             10,948      20,019      30,967    Q1a           118.8±14.64   0.61±0.26    194.75
            Note: These values were calculated by measuring the distance between   Q2a  136.0±21.68  1.58±0.16  86.65
            the side chain atoms and the catalytic residues, His41 and Cys145.  Q3a  >160  2.03±0.35    >78.82
                                                               Q4a           84.7±9.78     2.24±0.47    37.82
            Table 4. Classification of conformations according to the
            distance between atoms H41:ND1/NE and C145:SG‑ of the   Q1b      >160          1.95±0.25    >82.05
            active site                                        Q2b           >160          2.09±0.27    >76.56
                                                               Q3b           >160          1.72±0.19    >93.02
            Conformation     Chain A           Chain B
                                                               Q4b           113.5±5.37    0.89±0.32    127.53
                       Distance Classification Distance Classification
                                                               Q1bS          >160          1.86±0.17    >86.02
            6209         2.9   Closed      4.3   Intermediate                                      WT
            10531        3.7   Closed      2.1   Closed
                                                               Note: EC  values were determined using the SARS-CoV-2 B.1 lineage
            17362        3.7   Closed      4.4   Intermediate  (WT).  50
            25647        4.9   Intermediate  5.9  Open         Abbreviations: CC : Concentration of molecules that promotes death
                                                                           50
                                                               in 50% of treated cells; EC : Concentration of molecules necessary
            28983        3.5   Closed      5.5   Open                           50
                                                               to obtain 50% of effective inhibitory activity; SI: Selectivity index
            36867        4.4   Intermediate  6.1  Open         (calculated by determining the ratio of CC  to EC ).
                                                                                          50   50
            treatment period (48 h), employing various SARS-CoV-2   for molecular docking studies to calculate the distance in
            viruses, including the B.1 lineage and the Omicron variant.  Å between these molecules and the C145 sulfur atom in
                                                                               pro
              The molecule concentration that causes death in 50%   the active site of M , cKi (µM), and affinity (kcal/mol)
            of treated cells (CC ), the molecule concentration capable   (Table 7).
                           50
            of reducing 50% of its effective activity (EC ), and the   4. Discussion
                                                 50
            selectivity index (CC /EC ) for all compounds are shown
                             50
                                 50
            in  Tables  5 (Vero E6) and  6 (Calu-3). Based on these   In recent years, a growing number of studies focused
            results, we selected the compounds Q3a and Q1b – Q4b   on the repurposing of clinically approved drugs have

            Volume 1 Issue 1 (2024)                         94                               doi: 10.36922/imo.3442
   95   96   97   98   99   100   101   102   103   104   105